Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 2:48 pm Unchanged |
2024-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
PFIZER INC PFE |
2,411,575 3.600% |
0 (Unchanged) |
Filing History |
| 2025-02-05 5:28 pm Purchase |
2024-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
BLACKROCK INC BLK |
2,840,909 4.300% |
105,328 (+3.85%) |
Filing History |
| 2024-12-17 4:06 pm Purchase |
2024-12-10 | 13G | Cardiff Oncology, Inc. CRDF |
Commodore Capital LP | 5,384,616 8.100% |
5,384,616 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Cardiff Oncology, Inc. CRDF |
BLACKROCK INC BLK |
2,735,581 5.900% |
0 (Unchanged) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Cardiff Oncology, Inc. CRDF |
BLACKROCK INC BLK |
2,735,581 5.900% |
2,063,614 (+307.10%) |
Filing History |
| 2024-02-06 4:01 pm Sale |
2023-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
ACORN BIOVENTURES, L.P. | 1,946,762 4.200% |
-1,096,411 (-36.03%) |
Filing History |
| 2023-02-14 12:47 pm Sale |
2022-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
CAXTON CORP | 983,607 2.200% |
-2,495,733 (-71.73%) |
Filing History |
| 2023-02-09 09:23 am Sale |
2022-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-3,523,012 (Position Closed) |
Filing History |
| 2023-01-26 1:30 pm Unchanged |
2023-01-26 | 13G | Cardiff Oncology, Inc. CRDF |
ACORN BIOVENTURES, L.P. | 3,043,173 6.380% |
0 (Unchanged) |
Filing History |
| 2023-01-26 1:28 pm Sale |
2022-09-13 | 13D | Cardiff Oncology, Inc. CRDF |
ACORN BIOVENTURES, L.P. | 3,043,173 6.380% |
-2,947,666 (-49.20%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Cardiff Oncology, Inc. CRDF |
BLACKROCK INC BLK |
671,967 1.600% |
-1,860,281 (-73.46%) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
CAXTON CORP | 3,479,340 8.100% |
380,893 (+12.29%) |
Filing History |
| 2022-02-14 4:04 pm Sale |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Corriente Advisors LLC | 0 0.000% |
-2,000,000 (Position Closed) |
Filing History |
| 2022-02-11 7:12 pm Sale |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Avidity Partners Management LP | 0 0.000% |
-2,153,600 (Position Closed) |
Filing History |
| 2022-02-10 2:25 pm Purchase |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
JANUS HENDERSON GROUP PLC JHG |
3,523,012 8.400% |
1,385,341 (+64.81%) |
Filing History |
| 2022-02-09 12:06 pm Sale |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
STATE STREET CORP STT |
693,445 1.650% |
-1,855,327 (-72.79%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
BLACKROCK INC BLK |
2,532,248 6.000% |
2,532,248 (New Position) |
Filing History |
| 2021-11-19 4:02 pm Purchase |
2021-11-18 | 13G | Cardiff Oncology, Inc. CRDF |
PFIZER INC PFE |
2,411,575 5.750% |
2,411,575 (New Position) |
Filing History |
| 2021-02-16 3:30 pm Purchase |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
CAXTON CORP | 3,098,447 8.800% |
1,140,204 (+58.23%) |
Filing History |
| 2021-02-16 06:18 am Purchase |
2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Corriente Advisors LLC | 2,000,000 5.660% |
2,000,000 (New Position) |
Filing History |